Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for endometrial cancer chemoprevention in obese women
NCT01697566Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2013
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in endometrial cancer (EC), sponsored by University of Texas MD Anderson Cancer Center. Started May 2013; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01697566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697566.